Profilo
William L.
Heyward worked as a Vice President at VaxGen, Inc. from 2000 to 2004.
He also worked as a Vice President-Clinical Research at Dynavax Technologies Corp.
in 2010-2011 and as a Vice President-Clinical Development at Osel, Inc. Dr. Heyward received his undergraduate degree from Emory University, his graduate degree from The Johns Hopkins University, and his doctorate from Georgia Health Sciences University.
Precedenti posizioni note di William L. Heyward
| Società | Posizione | Fine |
|---|---|---|
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Osel, Inc.
 Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | Direttore Tecnico/Scientifico/R&S | - |
| DYNAVAX TECHNOLOGIES CORPORATION | Direttore Tecnico/Scientifico/R&S | - |
Formazione di William L. Heyward
| Emory University | Undergraduate Degree |
| Georgia Health Sciences University | Doctorate Degree |
| The Johns Hopkins University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Osel, Inc.
Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | Health Technology |
- Borsa valori
- Insiders
- William L. Heyward